Information Provided By: 
Fly News Breaks for June 7, 2017
WAT, A, DHR
Jun 7, 2017 | 08:41 EDT
As previously reported, Janney Capital analyst Paul Knight downgraded Danaher (DHR) to Neutral from Buy, stating that he sees the company having more work to do optimizing its portfolio. He believe peers such as Waters (WAT) and Agilent (A) are more likely to see upward growth revisions compared to Danaher, where he feels a meaningful acceleration in organic growth is already priced in. He keeps a $95 fair value estimate on Danaher shares.
News For DHR;A;WAT From the Last 2 Days
DHR
Apr 24, 2024 | 07:22 EDT
DHR
Apr 24, 2024 | 06:40 EDT
Baird raised the firm's price target on Danaher to $271 from $259 and keeps an Outperform rating on the shares. The firm said they reported 1Q results above expectations, helped by respiratory testing and bioprocessing upside. The company saw encouraging bioprocessing trends, with orders growing mid-single-digits, and noted normalization of large customer ordering patterns, with management expecting destocking to be largely complete by 2Q24-end.
DHR
Apr 24, 2024 | 06:32 EDT
DHR
Apr 24, 2024 | 05:28 EDT
Barclays raised the firm's price target on Danaher to $270 from $260 and keeps an Equal Weight rating on the shares post the Q1 report. The company's orders came in above expectations, the analyst tells investors in a research note. The firm says bioprocessing names continue to be favored by investors and that it does not see this changing in the near term.
DHR
Apr 23, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Globe Life (GL) $71.33 +4.94, Super Micro (SMCI) $764.85 +47.83, Danaher (DHR) $250.88 +14.79, Kimberly Clark (KMB) $136.87 +7.94, and General Motors (GM) $45.38 +2.17.
DHR
Apr 23, 2024 | 09:04 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
DHR
Apr 23, 2024 | 06:06 EDT
DHR
Apr 23, 2024 | 06:05 EDT
DHR
Apr 23, 2024 | 06:04 EDT
